Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 510 entries
Sorted by: Best Match Show Resources per page
[Some characteristics of beta-glucuronidase in human blood].

Bollettino della Societa italiana di biologia sperimentale

Scoppa P, Marafante E.
PMID: 5400865
Boll Soc Ital Biol Sper. 1969 Dec 31;45(24):1619-22.

No abstract available.

Cite
Scoppa P, Marafante E. Alcune caratteristiche della beta-glucuronidasi nel siero umano. [Some characteristics of beta-glucuronidase in human blood]. Boll Soc Ital Biol Sper. 1969;45(24):1619-22
Scoppa, P., & Marafante, E. (1969). Alcune caratteristiche della beta-glucuronidasi nel siero umano. [Some characteristics of beta-glucuronidase in human blood]. Bollettino della Societa italiana di biologia sperimentale, 45(24), 1619-22.
Scoppa, P, and Marafante, E. "Alcune caratteristiche della beta-glucuronidasi nel siero umano." [Some characteristics of beta-glucuronidase in human blood]. Bollettino della Societa italiana di biologia sperimentale vol. 45,24 (1969): 1619-22.
Scoppa P, Marafante E. Alcune caratteristiche della beta-glucuronidasi nel siero umano. [Some characteristics of beta-glucuronidase in human blood]. Boll Soc Ital Biol Sper. 1969 Dec 31;45(24):1619-22. Italian. PMID: 5400865.
Copy Download .nbib Format: NLM
Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS).

Molecular genetics and metabolism reports

Bodamer O, Scarpa M, Hung C, Pulles T, Giugliani R.
PMID: 28516041
Mol Genet Metab Rep. 2017 May 03;11:62-64. doi: 10.1016/j.ymgmr.2017.02.004. eCollection 2017 Jun.

There is a need to identify early disease markers to facilitate diagnosis of mucopolysaccharidosis type II (MPS II; Hunter syndrome). Mean birth weight and its association with disease severity was investigated in 609 patients enrolled in the Hunter Outcome...

Cite
Bodamer O, Scarpa M, Hung C, et al. Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS). Mol Genet Metab Rep. 2017;11:62-64doi: 10.1016/j.ymgmr.2017.02.004.
Bodamer, O., Scarpa, M., Hung, C., Pulles, T., & Giugliani, R. (2017). Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS). Molecular genetics and metabolism reports, 1162-64. https://doi.org/10.1016/j.ymgmr.2017.02.004
Bodamer, Olaf, et al. "Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS)." Molecular genetics and metabolism reports vol. 11 (2017): 62-64. doi: https://doi.org/10.1016/j.ymgmr.2017.02.004
Bodamer O, Scarpa M, Hung C, Pulles T, Giugliani R. Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS). Mol Genet Metab Rep. 2017 May 03;11:62-64. doi: 10.1016/j.ymgmr.2017.02.004. eCollection 2017 Jun. PMID: 28516041; PMCID: PMC5426030.
Copy Download .nbib Format: NLM
Transfer Printed P3HT/PCBM Photoactive Layers: From Material Intermixing to Device Characteristics.

ACS applied materials & interfaces

Abdellah A, Falco A, Schwarzenberger U, Scarpa G, Lugli P.
PMID: 26754413
ACS Appl Mater Interfaces. 2016 Feb 03;8(4):2644-51. doi: 10.1021/acsami.5b10539. Epub 2016 Jan 21.

The fabrication of organic electronic devices involving complex stacks of solution-processable functional materials has proven challenging. Significant material intermixing often occurs as a result of cross-solubility and postdeposition treatments, rendering the realization of even the simplest bilayer architectures rather...

Cite
Abdellah A, Falco A, Schwarzenberger U, et al. Transfer Printed P3HT/PCBM Photoactive Layers: From Material Intermixing to Device Characteristics. ACS Appl Mater Interfaces. 2016;8(4):2644-51doi: 10.1021/acsami.5b10539.
Abdellah, A., Falco, A., Schwarzenberger, U., Scarpa, G., & Lugli, P. (2016). Transfer Printed P3HT/PCBM Photoactive Layers: From Material Intermixing to Device Characteristics. ACS applied materials & interfaces, 8(4), 2644-51. https://doi.org/10.1021/acsami.5b10539
Abdellah, Alaa, et al. "Transfer Printed P3HT/PCBM Photoactive Layers: From Material Intermixing to Device Characteristics." ACS applied materials & interfaces vol. 8,4 (2016): 2644-51. doi: https://doi.org/10.1021/acsami.5b10539
Abdellah A, Falco A, Schwarzenberger U, Scarpa G, Lugli P. Transfer Printed P3HT/PCBM Photoactive Layers: From Material Intermixing to Device Characteristics. ACS Appl Mater Interfaces. 2016 Feb 03;8(4):2644-51. doi: 10.1021/acsami.5b10539. Epub 2016 Jan 21. PMID: 26754413.
Copy Download .nbib Format: NLM
Munchausen's Syndrome in Plastic Surgery: An Interdisciplinary Challenge.

Plastic and reconstructive surgery. Global open

Pavan C, Scarpa C, Bassetto F, Azzi M, Vindigni V.
PMID: 26180729
Plast Reconstr Surg Glob Open. 2015 Jul 08;3(6):e428. doi: 10.1097/GOX.0000000000000378. eCollection 2015 Jun.

Munchausen's syndrome is a rare psychiatric disease. We report a case in which we have collaborated with the psychiatrist for the diagnosis and also propose a diagnostic flowchart.

Cite
Pavan C, Scarpa C, Bassetto F, et al. Munchausen's Syndrome in Plastic Surgery: An Interdisciplinary Challenge. Plast Reconstr Surg Glob Open. 2015;3(6):e428doi: 10.1097/GOX.0000000000000378.
Pavan, C., Scarpa, C., Bassetto, F., Azzi, M., & Vindigni, V. (2015). Munchausen's Syndrome in Plastic Surgery: An Interdisciplinary Challenge. Plastic and reconstructive surgery. Global open, 3(6), e428. https://doi.org/10.1097/GOX.0000000000000378
Pavan, Chiara, et al. "Munchausen's Syndrome in Plastic Surgery: An Interdisciplinary Challenge." Plastic and reconstructive surgery. Global open vol. 3,6 (2015): e428. doi: https://doi.org/10.1097/GOX.0000000000000378
Pavan C, Scarpa C, Bassetto F, Azzi M, Vindigni V. Munchausen's Syndrome in Plastic Surgery: An Interdisciplinary Challenge. Plast Reconstr Surg Glob Open. 2015 Jul 08;3(6):e428. doi: 10.1097/GOX.0000000000000378. eCollection 2015 Jun. PMID: 26180729; PMCID: PMC4494498.
Copy Download .nbib Format: NLM
Quantification of intracellular payload release from polymersome nanoparticles.

Scientific reports

Scarpa E, Bailey JL, Janeczek AA, Stumpf PS, Johnston AH, Oreffo RO, Woo YL, Cheong YC, Evans ND, Newman TA.
PMID: 27404770
Sci Rep. 2016 Jul 11;6:29460. doi: 10.1038/srep29460.

Polymersome nanoparticles (PMs) are attractive candidates for spatio-temporal controlled delivery of therapeutic agents. Although many studies have addressed cellular uptake of solid nanoparticles, there is very little data available on intracellular release of molecules encapsulated in membranous carriers, such...

Cite
Scarpa E, Bailey JL, Janeczek AA, et al. Quantification of intracellular payload release from polymersome nanoparticles. Sci Rep. 2016;6:29460doi: 10.1038/srep29460.
Scarpa, E., Bailey, J. L., Janeczek, A. A., Stumpf, P. S., Johnston, A. H., Oreffo, R. O., Woo, Y. L., Cheong, Y. C., Evans, N. D., & Newman, T. A. (2016). Quantification of intracellular payload release from polymersome nanoparticles. Scientific reports, 629460. https://doi.org/10.1038/srep29460
Scarpa, Edoardo, et al. "Quantification of intracellular payload release from polymersome nanoparticles." Scientific reports vol. 6 (2016): 29460. doi: https://doi.org/10.1038/srep29460
Scarpa E, Bailey JL, Janeczek AA, Stumpf PS, Johnston AH, Oreffo RO, Woo YL, Cheong YC, Evans ND, Newman TA. Quantification of intracellular payload release from polymersome nanoparticles. Sci Rep. 2016 Jul 11;6:29460. doi: 10.1038/srep29460. PMID: 27404770; PMCID: PMC4941396.
Copy Download .nbib Format: NLM
Interpersonal Counseling (IPC) for Depression in Primary Care.

American journal of psychotherapy

Weissman MM, Hankerson SH, Scorza P, Olfson M, Verdeli H, Shea S, Lantigua R, Wainberg M.
PMID: 26453343
Am J Psychother. 2014;68(4):359-83. doi: 10.1176/appi.psychotherapy.2014.68.4.359.

Interpersonal Counseling (IPC) comes directly from interpersonal psychotherapy (IPT), an evidenced-based psychotherapy developed by Klerman and Weissman. It [IPC?] is a briefer, more structured version for use primarily in non-mental health settings, such as primary care clinics when treating...

Cite
Weissman MM, Hankerson SH, Scorza P, et al. Interpersonal Counseling (IPC) for Depression in Primary Care. Am J Psychother. 2014;68(4):359-83doi: 10.1176/appi.psychotherapy.2014.68.4.359.
Weissman, M. M., Hankerson, S. H., Scorza, P., Olfson, M., Verdeli, H., Shea, S., Lantigua, R., & Wainberg, M. (2014). Interpersonal Counseling (IPC) for Depression in Primary Care. American journal of psychotherapy, 68(4), 359-83. https://doi.org/10.1176/appi.psychotherapy.2014.68.4.359
Weissman, Myrna M, et al. "Interpersonal Counseling (IPC) for Depression in Primary Care." American journal of psychotherapy vol. 68,4 (2014): 359-83. doi: https://doi.org/10.1176/appi.psychotherapy.2014.68.4.359
Weissman MM, Hankerson SH, Scorza P, Olfson M, Verdeli H, Shea S, Lantigua R, Wainberg M. Interpersonal Counseling (IPC) for Depression in Primary Care. Am J Psychother. 2014;68(4):359-83. doi: 10.1176/appi.psychotherapy.2014.68.4.359. PMID: 26453343; PMCID: PMC4603528.
Copy Download .nbib Format: NLM
The biological clock and the molecular basis of lysosomal storage diseases.

JIMD reports

Mazzoccoli G, Mazza T, Vinciguerra M, Castellana S, Scarpa M.
PMID: 25583520
JIMD Rep. 2015;18:93-105. doi: 10.1007/8904_2014_354. Epub 2015 Jan 13.

The lysosomal storage disorders encompass nearly fifty diseases provoked by lack or deficiency of enzymes essential for the breakdown of complex molecules and hallmarked by accumulation in the lysosomes of metabolic residues. Histochemistry and cytochemistry studies evidenced patterns of...

Cite
Mazzoccoli G, Mazza T, Vinciguerra M, et al. The biological clock and the molecular basis of lysosomal storage diseases. JIMD Rep. 2015;18:93-105doi: 10.1007/8904_2014_354.
Mazzoccoli, G., Mazza, T., Vinciguerra, M., Castellana, S., & Scarpa, M. (2015). The biological clock and the molecular basis of lysosomal storage diseases. JIMD reports, 1893-105. https://doi.org/10.1007/8904_2014_354
Mazzoccoli, Gianluigi, et al. "The biological clock and the molecular basis of lysosomal storage diseases." JIMD reports vol. 18 (2015): 93-105. doi: https://doi.org/10.1007/8904_2014_354
Mazzoccoli G, Mazza T, Vinciguerra M, Castellana S, Scarpa M. The biological clock and the molecular basis of lysosomal storage diseases. JIMD Rep. 2015;18:93-105. doi: 10.1007/8904_2014_354. Epub 2015 Jan 13. PMID: 25583520; PMCID: PMC4361918.
Copy Download .nbib Format: NLM
Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation.

Radiology and oncology

Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, Claudio B.
PMID: 26029026
Radiol Oncol. 2015 Mar 25;49(2):147-54. doi: 10.1515/raon-2015-0013. eCollection 2015 Jun.

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease generally refractory to standard chemotherapeutic agents; therefore improvements in anticancer therapies are mandatory. A major determinant of therapeutic resistance in PDAC is the poor drug delivery to neoplastic cells, mainly...

Cite
Girelli R, Prejanò S, Cataldo I, et al. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol. 2015;49(2):147-54doi: 10.1515/raon-2015-0013.
Girelli, R., Prejanò, S., Cataldo, I., Corbo, V., Martini, L., Scarpa, A., & Claudio, B. (2015). Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiology and oncology, 49(2), 147-54. https://doi.org/10.1515/raon-2015-0013
Girelli, Roberto, et al. "Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation." Radiology and oncology vol. 49,2 (2015): 147-54. doi: https://doi.org/10.1515/raon-2015-0013
Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, Claudio B. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol. 2015 Mar 25;49(2):147-54. doi: 10.1515/raon-2015-0013. eCollection 2015 Jun. PMID: 26029026; PMCID: PMC4387991.
Copy Download .nbib Format: NLM
Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management: Spanish Scenario.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Scarpa F.
PMID: 27201453
Value Health. 2014 Nov;17(7):A490-1. doi: 10.1016/j.jval.2014.08.1448. Epub 2014 Oct 26.

No abstract available.

Cite
Scarpa F. Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management: Spanish Scenario. Value Health. 2014;17(7):A490-1doi: 10.1016/j.jval.2014.08.1448.
Scarpa, F. (2014). Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management: Spanish Scenario. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A490-1. https://doi.org/10.1016/j.jval.2014.08.1448
Scarpa, F. "Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management: Spanish Scenario." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A490-1. doi: https://doi.org/10.1016/j.jval.2014.08.1448
Scarpa F. Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management: Spanish Scenario. Value Health. 2014 Nov;17(7):A490-1. doi: 10.1016/j.jval.2014.08.1448. Epub 2014 Oct 26. PMID: 27201453.
Copy Download .nbib Format: NLM
[European Reference Networks : Consequences for healthcare in Germany].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Graessner H, Schäfer F, Scarpa M, Wagner TOF.
PMID: 28275837
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):537-541. doi: 10.1007/s00103-017-2533-x.

Starting in 2017, European Reference Networks (ERNs) for rare disease patients will be established in the European Union. ERNs will pool expertise in clinical centres and will establish cross-border exchange mechanisms in order to facilitate access to diagnosis and...

Cite
Graessner H, Schäfer F, Scarpa M, et al. Europäische Referenznetzwerke : Konsequenzen für die Gesundheitsversorgung in Deutschland. [European Reference Networks : Consequences for healthcare in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60(5):537-541doi: 10.1007/s00103-017-2533-x.
Graessner, H., Schäfer, F., Scarpa, M., & Wagner, T. O. F. (2017). Europäische Referenznetzwerke : Konsequenzen für die Gesundheitsversorgung in Deutschland. [European Reference Networks : Consequences for healthcare in Germany]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 60(5), 537-541. https://doi.org/10.1007/s00103-017-2533-x
Graessner, Holm, et al. "Europäische Referenznetzwerke : Konsequenzen für die Gesundheitsversorgung in Deutschland." [European Reference Networks : Consequences for healthcare in Germany]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz vol. 60,5 (2017): 537-541. doi: https://doi.org/10.1007/s00103-017-2533-x
Graessner H, Schäfer F, Scarpa M, Wagner TOF. Europäische Referenznetzwerke : Konsequenzen für die Gesundheitsversorgung in Deutschland. [European Reference Networks : Consequences for healthcare in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):537-541. doi: 10.1007/s00103-017-2533-x. German. PMID: 28275837.
Copy Download .nbib Format: NLM
Blocked Shape Memory Effect in Negative Poisson's Ratio Polymer Metamaterials.

ACS applied materials & interfaces

Boba K, Bianchi M, McCombe G, Gatt R, Griffin AC, Richardson RM, Scarpa F, Hamerton I, Grima JN.
PMID: 27377708
ACS Appl Mater Interfaces. 2016 Aug 10;8(31):20319-28. doi: 10.1021/acsami.6b02809. Epub 2016 Jul 26.

We describe a new class of negative Poisson's ratio (NPR) open cell PU-PE foams produced by blocking the shape memory effect in the polymer. Contrary to classical NPR open cell thermoset and thermoplastic foams that return to their auxetic...

Cite
Boba K, Bianchi M, McCombe G, et al. Blocked Shape Memory Effect in Negative Poisson's Ratio Polymer Metamaterials. ACS Appl Mater Interfaces. 2016;8(31):20319-28doi: 10.1021/acsami.6b02809.
Boba, K., Bianchi, M., McCombe, G., Gatt, R., Griffin, A. C., Richardson, R. M., Scarpa, F., Hamerton, I., & Grima, J. N. (2016). Blocked Shape Memory Effect in Negative Poisson's Ratio Polymer Metamaterials. ACS applied materials & interfaces, 8(31), 20319-28. https://doi.org/10.1021/acsami.6b02809
Boba, Katarzyna, et al. "Blocked Shape Memory Effect in Negative Poisson's Ratio Polymer Metamaterials." ACS applied materials & interfaces vol. 8,31 (2016): 20319-28. doi: https://doi.org/10.1021/acsami.6b02809
Boba K, Bianchi M, McCombe G, Gatt R, Griffin AC, Richardson RM, Scarpa F, Hamerton I, Grima JN. Blocked Shape Memory Effect in Negative Poisson's Ratio Polymer Metamaterials. ACS Appl Mater Interfaces. 2016 Aug 10;8(31):20319-28. doi: 10.1021/acsami.6b02809. Epub 2016 Jul 26. PMID: 27377708.
Copy Download .nbib Format: NLM
Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model.

Autoimmunity

Di Liddo R, Valente S, Taurone S, Zwergel C, Marrocco B, Turchetta R, Conconi MT, Scarpa C, Bertalot T, Schrenk S, Mai A, Artico M.
PMID: 26789595
Autoimmunity. 2016 Jan 20;1-11. doi: 10.3109/08916934.2015.1134510. Epub 2016 Jan 20.

Among epigenetic enzymes, histone deacetylases (HDACs) are responsible for regulating the expression of an extensive array of genes by reversible deacetylation of nuclear histones as well as a large number of non-histone proteins. Initially proposed for cancer therapy, recently...

Cite
Di Liddo R, Valente S, Taurone S, et al. Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model. Autoimmunity. 2016;1-11doi: 10.3109/08916934.2015.1134510.
Di Liddo, R., Valente, S., Taurone, S., Zwergel, C., Marrocco, B., Turchetta, R., Conconi, M. T., Scarpa, C., Bertalot, T., Schrenk, S., Mai, A., & Artico, M. (2016). Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model. Autoimmunity, 1-11. https://doi.org/10.3109/08916934.2015.1134510
Di Liddo, Rosa, et al. "Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model." Autoimmunity vol. (2016): 1-11. doi: https://doi.org/10.3109/08916934.2015.1134510
Di Liddo R, Valente S, Taurone S, Zwergel C, Marrocco B, Turchetta R, Conconi MT, Scarpa C, Bertalot T, Schrenk S, Mai A, Artico M. Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model. Autoimmunity. 2016 Jan 20;1-11. doi: 10.3109/08916934.2015.1134510. Epub 2016 Jan 20. PMID: 26789595.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 510 entries